Totally sucks, why would they do a seeking alpha article, at least do a interview with a respected journalist. The excuse of not diluting does not cut it for me, they still gonna have to pay for all the salaries and the other trials. This needs to stay above 35 cents or per the agreement with aspire they can't even raise funds through them. What response was stated?
(0)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links